-
Photovoltaic 24
-
Wind energy 6
-
Other renewable energy (nuclear, geothermal, etc.) 22
-
Grid/power transmission 23
-
Energy storage 31
-
Hydrogen energy 10
-
Lithium batteries 48
-
Electric vehicles 45
-
Low-carbon buildings and construction 7
-
Agriculture 11
-
Low-carbon consumer goods 6
-
New materials 22
-
Industrial manufacturing 7
-
Green transportation 22
-
CCUS 2
-
Digital technology for carbon accounting and consulting 22
-
Bio-Tech 2
-
Circular economy 31
All investors
114 institutional investors
Content Filter
-
Photovoltaic 24
-
Wind energy 6
-
Other renewable energy (nuclear, geothermal, etc.) 22
-
Grid/power transmission 23
-
Energy storage 31
-
Hydrogen energy 10
-
Lithium batteries 48
-
Electric vehicles 45
-
Low-carbon buildings and construction 7
-
Agriculture 11
-
Low-carbon consumer goods 6
-
New materials 22
-
Industrial manufacturing 7
-
Green transportation 22
-
CCUS 2
-
Digital technology for carbon accounting and consulting 22
-
Bio-Tech 2
-
Circular economy 31
-
Qiming VC
- Investments: 671
- Funds: 26
- Shanghai
-
Lithium batteries
-
Electric vehicles
-
Low-carbon consumer goods
-
Digital technology for carbon accounting and consulting
-
Circular economy
Qiming Venture Partners is a top-tier VC firm with outstanding reputation. With our exceptional investment performances, we have been widely recognized by investors from around the world. We have a reputation for being entrepreneur friendly.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.4 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages. Many of our portfolio companies are today’s most influential firms in their respective sectors, including Xiaomi , Meituan, Bilibili, Zhihu, Roborock, Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, Schrödinger, APT Medical, New Horizon Health, Venus MedTech, Sanyou Medical, AmoyDx， Berry Genomics, SinocellTech, Yuanxin Technology, dMed-Clinipace, Belief BioMed, WeRide, Biren Technology and UBTech among many others.
-
Huaxing Growth Capital
- Investments: 118
- Funds: 54
- Shanghai
-
Electric vehicles
Founded in 2005, China Renaissance("CR") is a leading financial institution that provides a full range of trusted services, including investment management, private placement, M&A advisory, equity underwriting, sales & trading, research and wealth management. CR Investment Banking was launched in 2005 and is one of the core businesses of the Group. Among them, the private placement financial advisory business has remained the first in the market for 17 consecutive years. The Group has a strong development momentum in the science and technology track, and is in a leading position in the medical and corporate service industries. CR's investment fields include intelligent manufacturing, science and technology, digital health, corporate services, new consumption and etc.
-
Tech Capital
- Investments: 8
- Funds: 0
- Jiaxing City, Zhejiang Province
-
New materials
-
Circular economy
Tech Capital is a four-in-one platform that provides scientific and technological innovation services, incubation of scientific and technological achievements, scientific and technological investment and technology trading for hard science and technology entrepreneurs. Relying on the scientific research strength of top science institutes and universities at home and abroad and the rich industrial resources and capital market experience of advantagous capitals, Tech Capital offers professional, in-depth and comprehensive investment, incubation and financing solutions for science and technology entrepreneurs, and is committed to building a platform for the industrialization of science and technology, technicalization of industry, clustering of science and technology, technology trading and combination of industry and investment. It helps turn science and technology into productivity, uses the power of capital to build a strong science and technology nation, equips industrial entities with science and technology and capitalizes science and technology enterprises, and supports cutting-edge science and technology enterprises in all areas, from intellectual property development to initial public offerings (IPO).
-
GSR United Capital
- Investments: 123
- Funds: 30
- Beijing
-
Agriculture
-
Circular economy
GSR United Capital focuses on equity investment in high-tech industries. We pay attention to investment and M&A opportunities in areas such as universal artificial intelligence (AI, robotics, advanced manufacturing, supply chain upgrades, etc.), industrial Internet, smart transportation, and environmental protection. Since our establishment in 2009, we have received strong support from China's top market-oriented funds of funds, government guidance funds, wealth management institutions, global top 500 companies, listed companies, and other institutions. We have invested companies, including Zhidou, Whalehouse, Fairsense, Belight, Freetech, and Doppler.
-
Matrix Partners
- Investments: 1162
- Funds: 30
- Beijing
-
Lithium batteries
-
Electric vehicles
-
Digital technology for carbon accounting and consulting
Founded in 2008, Matrix Partners China is one of the leading venture capital firms focused on early stage and early growth deals in China, now managing over 50 billion yuan. Matrix Partners China mainly invests in new technology, hard technology, industrial digitalization, healthcare, frontier technology and new consumer brands. The firm has invested in more than 700 companies, including XPeng, Li-Auto, Futu Securities, Guazi，Eleme, Youzan, Ronbay, Xgimi, Momo, PingCap, Peijia Medical, Career International, Chemclin, Beisen, Lexin, ZiHaiGuo, ITcast, METAX, Simple Love, SemiDrive, MegaRobo, Akrostar Technology, X-EPIC, Bota Bio, Advaccine and so on.